← All Aspen Aerogels INC filings

Aspen Aerogels INC 10-K annual reports

Annual reports — audited financials, the full risk-factor list, and management’s account of the year.

NYSE
ASPN
Aspen Aerogels INC
10-K/A: Aspen Aerogels Amends 10-K, Reveals Deep 2025 Losses
Aspen Aerogels, Inc. filed an amended annual report correcting an inventory balance error, while the underlying financials reveal a significant net loss and revenue decline for 2025.
NYSE
ASPN
Aspen Aerogels INC
10-K: Aspen Aerogels Reports Steep 2025 Losses Amid EV Market Slowdown
Aspen Aerogels, Inc. reported a significant net loss of $389.6 million in 2025, driven by a 40% revenue decline and a substantial impairment charge related to its Statesboro Plant.
NYSE
ASPN
Aspen Aerogels INC
10-K: Aspen Aerogels Reports Strong Revenue Growth Driven by Thermal Barrier and Energy Industrial Segments in 2024
Aspen Aerogels' 2024 10-K filing reveals significant revenue growth, driven by increased demand for thermal barrier products and sustained performance in the energy industrial sector.
NYSE
ASPN
Aspen Aerogels INC
10-K: Aspen Aerogels Updates Code of Business Conduct and Ethics, Reinforces Compliance
Aspen Aerogels has updated its Code of Business Conduct and Ethics, emphasizing ethical and legal standards for all associates.